Crisaborole 2 % Topical Ointment
RxNorm 1865957
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1865957 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: crisaborole 2 % Topical Ointment.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Crisaborole 0.02 mg/MG Topical Ointment
(Atom ID: 8713677)
PSNPrescribable
Prescribable Name (PSN):
Crisaborole 2 % Topical Ointment
(Atom ID: 8713688)
SYPrescribable
Synonym (SY):
Crisaborole 2 % Topical Ointment
(Atom ID: 8713687)
PTPrescribable
Designated preferred name (PT):
Crisaborole 20 mg/g cutaneous ointment
(Atom ID: 12536698)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely crisaborole 20 mg/1 gram conventional release cutaneous ointment (clinical drug)
(Atom ID: 12537606)
Patient Education
Crisaborole Topical
Crisaborole is used to treat eczema (atopic dermatitis; a skin condition which causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in adults and children 3 years of age and older. Crisaborole is in a class of medications called phosphodiesterase inhibitors. It works by blocking the action of certain natural substances in the body that cause inflammation.
[Learn More]
* Please review the disclaimer below.